Heated chemo during surgery may fight chest tumor spread

NCT ID NCT07383142

Not yet recruiting Disease control Sponsor: Shanghai Zhongshan Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares surgery alone to surgery plus heated chemotherapy (HITOC) for people with thymic tumors that have spread to the lining of the chest. About 202 participants will be randomly assigned to one of the two groups. The goal is to see if adding HITOC helps keep the cancer from coming back longer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: doxorubicin and cisplatin (heated chemotherapy)
What this could lead to: If it works, this could offer a better way to control thymic tumors that have spread to the chest lining, potentially delaying recurrence.
What could go wrong: This is a Phase 3 trial, but it hasn't started recruiting yet. The heated chemotherapy adds risks like infection or organ damage, and it may not improve survival over surgery alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THYMIC EPITHELIAL TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

thymic epithelial neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

THYMIC EPITHELIAL TUMOR

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Shanghai Zhongshan Hospital

Shanghai, 200032, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.